20 year-old Male with Destructive Lesion of Orbital Roof
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Patient History
Mr. G.R. is a 20-year-old man with no significant past medical
history. He presented in July of 2013 with two months of
worsening pain over the right orbit. Periorbital edema was also
present. Initial treatment with eye drops, antibiotics
(erythromycin followed by cephalexin), and steroids
(prednisone) failed to control his symptoms.
In October of 2013, CT and MRI scans revealed a permeative
destructive lesion centered in the right orbital roof with extension
into the superior orbit and the floor of the anterior cranial fossa.
There was no abnormal enhancement in the visualized brain
parenchyma.
The radiologic appearance of the mass suggested a differential
diagnosis of a lymphoma, a metastasis, an eosinophilic
histiocytosis, or an infection.
In November of 2013, the patient underwent a frontal
craniotomy for resection of a 2.4 cm mass in the orbital rim.
Langerhans cell histiocytosis was diagnosed by frozen section
and confirmed by immunohistochemistry.
In December of 2013, the patient was seen for surgical follow-up
at which time his pain, swelling, and erythema had completely
resolved. There were no visual abnormalities present.

Microscopic Pathology and Immunohistochemical
Stains

Diagnosis
The differential diagnosis for a 2.4 cm mass causing bony destruction of the
superior orbital rim includes a histiocytic lesion, lymphoma, a metastasis, or
an infection. Hematoxylin and Eosin and immunohistochemical stains such
as CD1a, S-100 protein, and CD68 are helpful in distinguishing amongst
these entities.
H&E stained sections revealed a histiocytic lesion with the presence of
large cells with grooved nuclei in addition to an abundance of eosinophils.
Erdheim-Chester disease, Langerhans cell histiocytosis, and RosaiDorfman disease are distinct histiocytic lesions that can be differentiated by
their patterns of S-100, CD1a and CD68 expression. CD68 expression is a
measure of lysosomal activity and marks all histiocytes. S-100 is a protein
expressed in Langerhans cells and the histiocytes of Rosai-Dorfman
disease, but not the histiocytes of Erdheim-Chester disease. CD1a is a
specific marker of dendritic cells including Langerhans cells. Strong
immunoreactivity for CD1a and S-100 along with low atypia and few
mitoses on H&E stain confirmed the diagnosis of Langerhans cell
histiocytosis.

Figure 3. H&E stain of the tumor
at 200x shows abundant eosinophils
and a proliferation of histiocytes.

Figure 4. H&E stain of the tumor at
1000x reveals large histiocytic cells
with grooved nuclei.

Discussion
Langerhans cells are mononuclear phagocytes derived from precursor cells
in the bone marrow. They are found in the epidermis, lymph nodes, spleen,
thymus and mucosal tissues. Langerhans cells ingest, process, and
present antigens to T lymphocytes. Langerhans cells have distinctive
characteristics, including cytoplasmic tennis racquet-shaped Birbeck
granules on electron microscopy.

Magnetic Resonance Imaging

Langerhans cell histiocytosis (LCH) represents a lesion of proliferating
histiocytes in the background of numerous eosinophils. LCH can present
either as an isolated bone lesion or a systemic process. An isolated lesion
is more common in children and young adults. Surgical excision of solitary
lesions is often curative.
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